The Translational Impact Research (TIR) funding program听supports large-scale translational research projects in RNA-based therapeutics, which address D2R鈥檚 strategic priorities, and have a measurable translational impact on the health of Canadians.

In the first funding cycle launched in 2024, 11 Letters of Intent were received of which four were invited to submit full applications. Three full applications were received and awarded.听View a summary of the review and selection process.

In the second funding cycle launched in 2025, 11 Letters of Intent were received of which four were invited to submit full applications. Four full applications were received and awarded. View a summary of the review and selection process.

听